USPTO serial 79368658
Serial No. 79368658
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 12, 2024
- Examiner
- BULLOFF, TOBY ELLEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79368658?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patricia A Wilczynski Brozek
Patricia A Wilczynski Brozek POKALSKY WILCZYNSKI BROZEK LLP40 Preston St., P.O. Box 1830Huntington, NY 11743UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific or medical research use; biological preparations for scientific or laboratory purposes; diagnostic preparations for scientific or research use; diagnostic reagents for scientific use; diagnostic preparations for scientific use; antibodies for scientific purposes, other than for medical or veterinary use; antibody reagents for scientific purposes; chemical reagents for scientific purposes; biological preparations for use in biotechnology other than medical use; reagents for cell transformation other than for medical or veterinary use; reagents for research purposes; chemical reagents for use in genetic research; reagents for medical research; diagnostic reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; reagents for chemical analyses; chemical reagents, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis | ACTIVE | — |
| 005 | Diagnostic reagents for immunization against disease; diagnostic test reagents for veterinary purposes; diagnostic agents for pharmaceutical use; biological and chemical reagents for medical or veterinary purposes; diagnostic test reagents for medical or veterinary purposes; biological preparations for medical or veterinary purposes, for treatment of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; biochemical preparations for medical or veterinary purposes, for treatment of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; biological reagents for medical purposes; biological preparations for medical purposes, for treatment of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; diagnostic chemical reagents for medical use; chemical preparations for testing blood for medical purposes; reagents for blood grouping for medical purposes; reactants for medical diagnosis; clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; antibodies for medical purposes; blood components for medical purposes; pharmaceutical preparations for use in hematology | ACTIVE | — |
| 010 | Home virus test kits comprised primarily of medical diagnostic apparatus for testing for viruses, test strips and reagents; medical measuring instruments for cancer diagnosis; apparatus for the diagnosis of inflammatory diseases; genetic testing apparatus for medical purposes; genetic verification apparatus for medical purposes; apparatus for DNA and RNA testing for medical purposes; immunofluorescence analysis apparatus for medical purposes; cell testing apparatus for medical purposes; medical genetic analyzer; apparatus for carrying-out diagnostic tests for medical purposes, namely, for diagnosis of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; medical diagnostic apparatus and instruments, namely, for diagnosis of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; diagnostic apparatus for medical purposes, namely, for diagnosis of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; ultrasonic diagnostic instruments for medical use; medical blood heaters; blood analysis apparatus for diagnosis; blood warmers; blood testing apparatus; apparatus for blood analysis; blood filters | ACTIVE | — |
| 042 | Genetic testing for scientific research purposes; DNA analysis for scientific research purposes; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of pharmacy; research in the field of gene analysis; scientific research in the field of genetics and genetic engineering; medical laboratories; scientific research in the field of biomedicine; analysis and evaluation of medical product development; blood testing for medical research; clinical research in the field of oncology, genetics, viral diseases, carcinoid tumors, pharmaceutical cancer treatment, lymphatic cancer, liquid biopsy, drug efficiency and drug resistance; blood analysis services; blood analysis services for scientific research purposes | ACTIVE | — |
| 044 | Medical and healthcare services relating to DNA, genetics and genetic testing; health care; physical examination services; medical analysis services for cancer diagnosis and prognosis; providing information in the field of cancer prevention, screening, diagnosis and treatment; genetic testing for medical purposes; DNA analysis for medical purposes; DNA screening for medical purposes; medical testing for diagnostic or treatment purposes; medical laboratory services for the analysis of blood samples; medical laboratory services for the analysis of blood samples taken from patients | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cytogen, Inc.
- Other trademarks owned by Cytogen, Inc.
- Other trademarks owned by Cytogen, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 11, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 21, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 21, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 13, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 12, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 12, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 2, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 26, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 26, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 6, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 6, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 6, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 27, 2023 | CRSN | CORRECTION SENT TO IB | — |
| Nov 27, 2023 | CRCR | CORRECTION CREATED FOR IB | — |
| Nov 20, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 16, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 16, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 25, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 2, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 2, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 20, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 19, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 5, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 4, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |